Publication | Closed Access

An economic evaluation of Losartan therapy in type 2 diabetic patients with nephropathy: an analysis of the RENAAL study adapted to France

Diabetes ManagementUrologyRenal DiseaseRenal FunctionHealth EconomicsHealth PolicyKidney FailureDiabetesChronic Kidney DiseaseType 2Diabetic Kidney DiseaseOutcomes ResearchLosartan TherapyEconomic EvaluationMedicineNephrology